TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 48 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2016. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $142,000 | -87.8% | 203,097 | -65.3% | 0.01% | -91.8% |
| Q2 2016 | $1,166,000 | +25.6% | 585,914 | +52.1% | 0.06% | +32.6% |
| Q1 2016 | $928,000 | -22.2% | 385,248 | +147.7% | 0.05% | -30.3% |
| Q4 2015 | $1,193,000 | +42.5% | 155,557 | -1.6% | 0.07% | +94.1% |
| Q3 2015 | $837,000 | +221.9% | 158,140 | +444.8% | 0.03% | +277.8% |
| Q2 2015 | $260,000 | +35.4% | 29,026 | -95.2% | 0.01% | +12.5% |
| Q1 2015 | $192,000 | -44.3% | 600,000 | +1090.6% | 0.01% | -38.5% |
| Q3 2014 | $345,000 | -87.2% | 50,394 | -73.2% | 0.01% | -88.8% |
| Q2 2014 | $2,696,000 | -5.8% | 187,894 | -31.7% | 0.12% | -28.0% |
| Q1 2014 | $2,863,000 | – | 275,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 392,952 | $4,051,000 | 0.53% |
| BLUESTEIN R H & CO LLC | 179,800 | $1,854,000 | 0.12% |
| Edge Wealth Management LLC | 15,000 | $154,000 | 0.07% |
| Tower Research Capital LLC (TRC) | 1,316 | $14,000 | 0.00% |
| VANGUARD GROUP INC | 37,190 | $384,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 100 | $1,000 | 0.00% |
| UBS AG | 1,878 | $19,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 106 | $1,000 | 0.00% |
| FIRST MANHATTAN CO. LLC. | 2,500 | $25,000 | 0.00% |
| CREDIT SUISSE AG/ | 19,370 | $200,000 | 0.00% |